UNSPSC 51101612: Polynoxylin

This classification denotes an antihelminthic agent with the molecular formula C2H6N2O2, chemically known as formaldehyde;urea but generally known as polynoxylin, which bears US NIH Compound Identifier 62705. European Medicines Agency schedules Polynoxylin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03939MIG. The term POLYNOXYLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5.). World Health Organization schedules polynoxylin in its Anatomical Therapeutic Chemical (ATC) Classification.

POLYNOXYLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule polynoxylin under HS 39091000 and SITC 57541. SMILES: C=O.C(=O)(N)N.

UNSPSC 51101612 Polynoxylin, a Commodity code, describes naloxone and related pharmaceutical products and systems procured by state and local health and human services agencies to support public health initiatives, community emergency response, and pharmacy benefit management. State and local governments buying under this code are acquiring naloxone units, safe drug deactivation systems, and generic pharmaceuticals through formal competitive procurements—not abstract medical supplies, but specific, often high-volume product purchases tied to fire rescue operations, county health departments, and statewide pharmacy networks. Issuing bodies span county health departments (Seminole County, Florida), city fire and rescue services (Tampa Fire Department), state pharmacy benefit and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). The scope includes emergency medical products for first responders, community health initiatives, and direct-to-manufacturer pharmaceutical distribution programs designed to improve cost efficiency and supply chain transparency.

Recent activity clusters in Florida and the upper Midwest, with additional involvement from Texas and Oregon through cooperative purchasing arrangements. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023. The City of Tampa's Purchasing Department released IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract amount of $700,000 and a small-local-business-enterprise set-aside designation offering a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and awards effective July 1, 2026 across participating state and local facilities in Minnesota and Oregon. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs, signaling potential future formal solicitations in pharmacy benefit program procurement.